Breeze Holdings Acquisition Corp.

announcedU=S+1WW=S@11.50
BRZHSEC EDGARCIK: 0001817640|Breeze Sponsor, LLC•Biopharmaceutical

Capital Structure & Economics

Trust Size$101,500,000
Unit Price$10.00
Warrant Coverage1/1
Sponsor Promote20%

Implied Equity Architecture

Capital Allocation Baseline

Trust (100.0%)

Implied Dilution Drag

100% Warrant Inclusion
Public Trust Allocation$101,500,000
Sponsor At-Risk CapitalN/A
Total Underwriting DiscountN/A
Trust Per Unit (Implied)$10.00
Sponsor Promote Allocation20%
Deal Lifecycle
IPO PricedOct 26, 2020
Target AnnouncedSep 24, 2024
Maturation Wall
N/A

Announced Target / M&A

  • Target CompanyYD Biopharma
  • SectorBiopharmaceutical
  • Announced Deal Size$647,304,110
  • Announcement Date2024-09-24

Board & Officers

  • J. Douglas RamseyCEO
  • J. Douglas Ramsey, Ph.D.(3)
    Director
  • Russell D. GriffinDirector
  • Charles C. Ross, P.E.Director
  • Albert McLelland(2)
    Director
  • Robert Lee ThomasDirector
  • James L. WilliamsDirector
  • Daniel L. HuntDirector
  • Bill StarkDirector
  • Dan HuntDirector
  • Albert S. McLellandDirector
  • Robert L. ThomasDirector

Advanced Structuring Terms

Target SectorsBiopharmaceutical

Syndicate & Advisors

Interactive Deal Modeling

Base financial constraints (Trust Size, Warrants, Promote) are pre-loaded into the calculation engines. Proceed to model implied dilution and advisory friction limits.

Dilution Cash Friction